Impact of Highly Active Antiretroviral Treatment on HIV Seroincidence Among Men Who Have Sex With Men: San Francisco
Mitchell H. Katz, MD,
Sandra K. Schwarcz, MD, MPH,
Timothy A. Kellogg, MA,
Jeffrey D. Klausner, MD, MPH,
James W. Dilley, MD,
Steven Gibson, MSW and
William McFarland, MD, PhD
Mitchell H. Katz, Sandra K. Schwarcz, Timothy A. Kellogg, Jeffrey Klausner, and William McFarland are with the San Francisco Department of Public Health, San Francisco, Calif. James W. Dilley is with the AIDS Health Project, University of California, San Francisco. Steven Gibson is with the Stop AIDS Project, San Francisco, Calif.
FIGURE 1—AIDS incidence, mortality, prevalence, and use of highly active antiretroviral therapy (HAART) among men who have sex with men (MSM): San Francisco, 19801999.
FIGURE 3—Hypothesized effect of highly active antiretroviral therapy (HAART) on HIV seroincidence among men who have sex with men (MSM) in San Francisco. GC = gonorrhea.